Gene polymorphisms of the renin–angiotensin system are involved in the pathophysiology of hypertension. We genotyped 4 polymorphisms of angiotensinogen (AGT) gene A-20C (rs5050), A-6G (rs5051), C3889T (rs4762), and C4072T (rs699) by polymerase chain reaction-restriction fragment length polymorphism in 652 patients and 780 controls to examine the association of AGT and hypertension in a Northern Han Chinese population. There were significant differences in the distribution of genotypes and allele frequencies at C4072T between the patients and the controls (both P < .01); patients with CC genotype had a higher risk of hypertension (odds ratio = 1.7, 95% confidence interval 1.4–2.1). The distribution of genotypes at A-6G was significantly different between patients and controls (P < .05). No other significant differences in genotypes or frequencies were observed. No association was observed between the haplotypes of AGT and hypertension. The AGT-6A and 4072C alleles are associated with susceptibility to hypertension in this population.
KearneyPMWheltonMReynoldsKMuntnerPWheltonPKHeJ. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217–223.
2.
LiuLS; Writing Group of 2010 Chinese Guidelines for the Management of Hypertension. 2010 Chinese guidelines for the management of hypertension [in Chinese]. Chin J Hypertens. 2011;19(8):701–743.
3.
BinderA. A review of the genetics of essential hypertension. Curr Opin Cardiol. 2007;22(3):176–184.
4.
CowleyAW Jr. The genetic dissection of essential hypertension. Nat Rev Genet. 2006;7(11):829–840.
5.
JeunemaitreXSoubrierFKotelevtsevYV. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71(1):169–180.
6.
ArmaniCBottoNAndreassiMG. Susceptibility genes in hypertension. Curr Pharm Des. 2011;17(28):2973–2986.
7.
JeunemaitreXInoueIWilliamsC. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60(6):1448–1460.
8.
InoueINakajimaTWilliamsCS. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99(7):1786–1797.
9.
BrandEChatelainNKeavneyB. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension. 1998;31(3):725–729.
10.
FardellaCEClaverieXVignoloPMonteroJVillarroelL. T235 variant of the angiotensinogen gene and blood pressure in the Chilean population. J Hypertens. 1998;16(6):829–833.
11.
FrossardPMHillSHElshahatYI. Associations of angiotensinogen gene mutations with hypertension and myocardial infarction in a gulf population. Clin Genet. 1998;54(4):285–293.
12.
HegeleRAHarrisSBHanleyAJSunFConnellyPW, Zinman B. -6A promoter variant of angiotensinogen and blood pressure variation in Canadian Oji-Cree. J Hum Genet. 1998; 43(1):37–41.
13.
BloemLJManatungaAKTewksburyDAPrattJH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95(3):948–953.
14.
KongXZhangSYangY. The relationship between haplotypes of angiotensinogen gene and essential hypertension [in Chinese]. Chin J Med Genet. 2002;19(6):488–490.
15.
KongXDYangYXZhangSZ. Haplotypes extending across AGT are associated essential hypertension [in Chinese]. Hereditas. 2004;26(6):797–802.
16.
Guidelines Subcommittee. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17(2):151–183.
17.
ZapataCCarolloCRodriguezS. Sampling variance and distribution of the D’ measure of overall gametic disequilibrium between multiallelic loci. Ann Hum Genet. 2001;65(pt 4):395–406.
18.
PereiraACMotaGFCunhaRSHerbenhoffFLMillJGKriegerJE. Angiotensinogen 235T allele “dosage” is associated with blood pressure phenotypes. Hypertension. 2003;41(1):25–30.
19.
DuprezDA. Role of the renin–angiotensin–aldosterone system in vascular remodeling and inflammation: a clinical review. J Hypertens. 2006;24(6):983–991.
20.
RotimiCMorrisonLCooperR. Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension. 1994;24(5):591–594.
21.
NiuTXuXRogusJ. Angiotensinogen gene and hypertension in Chinese. J Clin Invest. 1998;101(1):188–194.
22.
NiuTYangJWangB. Angiotensinogen gene polymorphisms M235T/T174M: no excess transmission to hypertensive Chinese. Hypertension. 1999;33(2):698–702.
23.
YuanJTangWChunYYingHYangYXiaoC. Angiotensinogen T174M and M235T variants and hypertension in the Hani and Yi minority groups of China. Biochem Genet. 2009;47(5-6):344–350.
24.
FangYJDengHBThomasGN. Linkage of angiotensinogen gene polymorphisms with hypertension in a sibling study of Hong Kong Chinese. J Hypertens. 2010;28(6):1203–1209.
25.
NiuWQiYHouSZhaiXZhouWQiuC. Haplotype-based association of the rennin–angiotensin system genes polymorphisms with essential hypertension among Han Chinese: the Fangshan study. J Hypertens. 2009;27(7):1384–1391.
26.
SunBDronmaTQinWJ. Polymorphisms of rennin–angiotensin system in essential hypertension in Chinese Tibetans. Biomed Environ Sci. 2004;17(2):209–216.
27.
NiuWQiYCenW. Genetic polymorphisms of angiotensinogen and essential hypertension in a Tibetan population. Hypertens Res. 2007;30(11):1129–1137.
28.
YanaiKNibuYMurakamiKFukamizuA. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J Biol Chem. 1996;271(27):15981–15986.
29.
YanaiKSaitoTHirotaKKobayashiHMurakamiKFukamizuA. Molecular variation of the human angiotensinogen core promoter element located between the TATA box and transcription initiation site affects its transcriptional activity. J Biol Chem. 1997;272(48):30558–30562.
30.
LarsonNHutchinsonRBoerwinkleE. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension. 2000;35(6):1297–1300.
31.
LiuYQiuCZhouWZhengYHouSCaoJ. Gene polymorphisms of the rennin-angiotensin system in essential hypertension. Chin Med J (Engl). 1999;112(2):115–120.
32.
YangCQiuCLuS. Association analysis of variants in the core promoter region of angiotensinogen gene with essential hypertension in Tibetan population [in Chinese]. Chin J Med Genet. 2000;17(3):149–152.
33.
WangGYWangYHXuQ. Genetic gene polymorphisms and interactions of hypertension in Mongolian people [in Chinese]. Chin J Public Health. 2006;22(11):1332–1333.
34.
LiuYQinWHouS. A-6G variant of the angiotensinogen gene and essential hypertension in Han, Tibetan, and Yi populations. Hypertens Res. 2001;24(2):159–163.
35.
IshigamiTTamuraKFujitaT. Angiotensinogen gene polymorphism near transcription start site and blood pressure: role of a T-to-C transition at intron I. Hypertension. 1999;34(3):430–434.
36.
WalkerWGWheltonPKSaitoHRussellRPHermannJ. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1979;1(3):287–291.
37.
ZhuHSagnellaGADongY. Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites. J Hypertens. 2003;21(1):87–95.
38.
AdeyemoAGerryNChenG. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet. 2009;5(7):e1000564.
39.
LarsonNHutchinsonRBoerwinkleE. Lack of association of 3 functional gene variants with hypertension in African Americans. Hypertension. 2000;35(6):1297–1300.
